Has Marianna Kiselev, MD received payments from drug or device companies?

Yes. Drug and device makers reported $718 in general payments to Marianna Kiselev, MD across 22 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marianna Kiselev, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marianna Kiselev, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marianna Kiselev, MD

Psychiatry · Long Branch, NJNPI 1366510927

Payments from drug & device makers

$718in general payments, 2019–2025

Across 22 payments — averaging $32.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alkermes, Inc.$210
Teva Pharmaceuticals USA, Inc.$141
Neurocrine Biosciences, Inc.$136
Otsuka America Pharmaceutical, Inc.$98
Indivior Inc.$76
Johnson & Johnson$42
plus $15 from 1 others

What the payments were for

Food & beverage$718100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alkermes, Inc.	3	$210
Teva Pharmaceuticals USA, Inc.	2	$141
Neurocrine Biosciences, Inc.	2	$136
Otsuka America Pharmaceutical, Inc.	6	$98
Indivior Inc.	5	$76
Johnson & Johnson	3	$42
AbbVie	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$718 in reported general payments places this provider in the 65th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey →

Medicare billing

Part B allowed, 2024

$31,467

Medicare patients

Services billed

369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clonazepam	16	$223
Mirtazapine	12	$200
Olanzapine	17	$171
Trazodone Hcl	18	$99
Atorvastatin Calcium	14	$90
Metoprolol Tartrate	12	$38

Paid to pharmacies, not to this prescriber.

Other psychiatry in Long Branch

Erika ConcepcionLong Branch$354K
Leon RosenbergCherry Hill$6.4M
Steven GlassClementon$3.9M
Judith JosephPaterson$3.8M
Jeffrey ApterPrinceton$1.7M
Roberta BallCherry Hill$741K
Marc CantillonLivingston$524K
Sanjay VarmaPrinceton$479K
Manuel SanchezNewark$474K
Robert BransfieldRed Bank$415K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →